MedCap AB (publ) (MCAP) - Total Liabilities
Based on the latest financial reports, MedCap AB (publ) (MCAP) has total liabilities worth Skr1.17 Billion SEK (≈ $125.89 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MedCap AB (publ) long-term investment allocation to see how much of total assets are deployed in long-term investments.
MedCap AB (publ) - Total Liabilities Trend (2007–2025)
This chart illustrates how MedCap AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MedCap AB (publ) total assets.
MedCap AB (publ) Competitors by Total Liabilities
The table below lists competitors of MedCap AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chongqing Road & Bridge Co Ltd
SHG:600106
|
China | CN¥1.72 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥3.31 Billion |
|
Hanma Technology Group Co Ltd
SHG:600375
|
China | CN¥5.60 Billion |
|
Zhejiang JW Precision Machinery Co.Ltd
SHE:300984
|
China | CN¥610.60 Million |
|
Anhui Estone Materials Technology Co Ltd
SHG:688733
|
China | CN¥1.65 Billion |
|
Guangzhou Pearl River Piano Group Co Ltd
SHE:002678
|
China | CN¥594.22 Million |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥6.71 Billion |
|
Beijing UniStrong Science & Technology Co Ltd
SHE:002383
|
China | CN¥1.48 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down MedCap AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MCAP equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MedCap AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MedCap AB (publ) (2007–2025)
The table below shows the annual total liabilities of MedCap AB (publ) from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.15 Billion ≈ $123.45 Million |
+63.13% |
| 2024-12-31 | Skr703.20 Million ≈ $75.68 Million |
+10.72% |
| 2023-12-31 | Skr635.10 Million ≈ $68.35 Million |
+11.30% |
| 2022-12-31 | Skr570.60 Million ≈ $61.41 Million |
+20.94% |
| 2021-12-31 | Skr471.80 Million ≈ $50.77 Million |
-1.56% |
| 2020-12-31 | Skr479.30 Million ≈ $51.58 Million |
-5.93% |
| 2019-12-31 | Skr509.50 Million ≈ $54.83 Million |
+28.95% |
| 2018-12-31 | Skr395.10 Million ≈ $42.52 Million |
+18.83% |
| 2017-12-31 | Skr332.50 Million ≈ $35.78 Million |
+22.75% |
| 2016-12-31 | Skr270.88 Million ≈ $29.15 Million |
-17.56% |
| 2015-12-31 | Skr328.57 Million ≈ $35.36 Million |
+22.36% |
| 2014-12-31 | Skr268.52 Million ≈ $28.90 Million |
-29.17% |
| 2013-12-31 | Skr379.09 Million ≈ $40.80 Million |
+123.95% |
| 2012-12-31 | Skr169.28 Million ≈ $18.22 Million |
+20.15% |
| 2011-12-31 | Skr140.88 Million ≈ $15.16 Million |
+8.34% |
| 2010-12-31 | Skr130.04 Million ≈ $13.99 Million |
-3.61% |
| 2009-12-31 | Skr134.90 Million ≈ $14.52 Million |
+102.90% |
| 2008-12-31 | Skr66.49 Million ≈ $7.16 Million |
-2.36% |
| 2007-12-31 | Skr68.10 Million ≈ $7.33 Million |
-- |
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more